Tenet Healthcare Raises FY2025 Adj EPS Guidance from $15.55-$16.21 to $15.93-$16.26 vs $15.68 Est; Raises FY2025 Sales Guidance from $20.950B-$21.250B to $21.150B-$21.350B vs $21.133B Est
Author: Benzinga Newsdesk | October 28, 2025 05:47am
Tenet Healthcare (NYSE:
THC) raises FY2025 Adj EPS guidance from $15.55-$16.21 to $15.93-$16.26 vs $15.68 analyst estimate. Raises FY2025 sales outlook from $20.950 billion-$21.250 billion to $21.150 billion-$21.350 billion vs $21.133 billion estimate.
Posted In: THC